Characteristics of Prostate Cancer Detected by Digital Rectal Examination Only

Urology

Volumn 70, Issue 6, 2007, Pages 1117-1120

  Okotie, Onisuru T ^a   Roehl, Kimberly A ^b   Han, Misop ^a   Loeb, Stacy ^c   Gashti, Sara N ^a   Catalona, William J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TREATMENT OUTCOME;

AGED; DIGITAL RECTAL EXAMINATION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 37349005496     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.07.019     Document Type: Article

References (14)

1. Carter H.B., Sauvageot J., Walsh P.C., et al. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate. J Urol 157 (1997) 2206-2209
2. Schroder F.H., Roobol-Bouts M., Vis A.N., et al. Prostate-specific antigen-based early detection of prostate cancer-validation of screening without rectal examination. Urology 57 (2001) 83-90
3. Smith D.S., and Catalona W.J. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45 (1995) 70-74
4. Sanchez-Chapado M., Angulo J.C., Ibarburen C., et al. Comparison of digital rectal examination, transrectal ultrasonography, and multicoil magnetic resonance imaging for preoperative evaluation of prostate cancer. Eur Urol 32 (1997) 140-149
5. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
6. Bozeman C.B., Carver B.S., Caldito G., et al. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. Urology 66 (2005) 803-807
7. Smith D.S., Humphrey P.A., and Catalona W.J. The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience. Cancer 80 (1997) 1852-1856
8. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-74 discussion 74-75
9. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156-1161
10. Beahrs O.H., Henson D.E., and Hutter R.V.P. Manual for Staging Cancer (1992), Lippincott, Philadelphia 181-183
11. Andriole G.L., Levin D.L., Crawford E.D., et al. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst 97 (2005) 433-438
12. Weinmann S., Richert-Boe K.E., Van Den Eeden S.K., et al. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology 16 (2005) 367-376
13. Philip J., Dutta Roy S., Ballal M., et al. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?. BJU Int 95 (2005) 969-971
14. Nagler H.M., Gerber E.W., Homel P., et al. Digital rectal examination is barrier to population-based prostate cancer screening. Urology 65 (2005) 1137-1140